Alcohol alternatives--a goal for psychopharmacology?
Ragan
C Ian
CI
CIR Consulting Ltd., 51 Slaidburn Street, London SW10 0JW, UK. ian.ragan1@btinternet.com
D000434:Alcoholic Beverages / Q000633:toxicity*; D000435:Alcoholic Intoxication / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D064420:Drug-Related Side Effects and Adverse Reactions; D004739:England; D058785:GABA-A Receptor Agonists; D040261:Harm Reduction; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors; D011600:Psychopharmacology; D019966:Substance-Related Disorders / Q000209:etiology*
D058785:GABA-A Receptor Agonists; D013287:Illicit Drugs; D016202:N-Methylaspartate